Señales en vivo de NPCE | Maximiza tus Ganancias con Getagraph.com

COMPRAR 126164 min ago

@ $16.08

Emitido: 12 feb 2024 @ 09:30

Retorno: -50.44%

Live Chart Being Loaded With Signals

Commentary (9 may 2024 @ 16:00):

Stats
Volumen de hoy	447 327
Volumen promedio	114 904
Capitalización de mercado	228.90M
EPS	$0 ( 2024-05-08 )
Próxima fecha de ganancias	( $0 ) 2024-08-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.28
ATR14	$0.0600 (0.75%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Orbimed Advisors Llc	Sell	15 690	Common Stock
2024-05-02	Orbimed Advisors Llc	Sell	8 842	Common Stock
2024-05-03	Orbimed Advisors Llc	Sell	4 674	Common Stock
2024-04-24	Orbimed Advisors Llc	Sell	1 781	Common Stock
2024-04-19	Orbimed Advisors Llc	Sell	18 253	Common Stock

INSIDER POWER
14.96
Last 97 transactions
Buy: 3 318 075 \| Sell: 1 148 594

Volumen Correlación

Largo: -0.49 (neutral)

Corto: -0.66 (moderate negative)

Signal:(24.282) Neutral

NeuroPace, Inc. Correlación

10 Correlaciones Más Positivas
ICCM	0.892
RBKB	0.891
PROV	0.891
ISTR	0.889
FCRD	0.889
CPLP	0.889
NSTS	0.88
ALTR	0.875
WTFCM	0.87
WLTW	0.859

10 Correlaciones Más Negativas
MLVF	-0.88
PFBI	-0.868
ADN	-0.862
RMRM	-0.861
XPDI	-0.856
BJDX	-0.85
CNSP	-0.847
BFRI	-0.844
KC	-0.843
RIBT	-0.837

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

NeuroPace, Inc. Correlación - Moneda/Commodity

-0.76
( moderate negative )

-0.18
( neutral )

0.00
( neutral )

0.41
( neutral )

0.73
( moderate )

0.09
( neutral )

NeuroPace, Inc. Finanzas

Annual	2023
Ingresos:	$65.42M
Beneficio Bruto:	$48.12M (73.56 %)
EPS:	$-1.270

FY	2023
Ingresos:	$65.42M
Beneficio Bruto:	$48.12M (73.56 %)
EPS:	$-1.270

FY	2022
Ingresos:	$45.52M
Beneficio Bruto:	$32.49M (71.38 %)
EPS:	$-2.17

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-1.497

Financial Reports:

No articles found.

NeuroPace, Inc.

NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.